As a preliminary study on NKX3.2 in cancers, publicly available gene expression databases such as Total Cancer Genome Atlas (TCGA) and Tumor Immune Estimation Resource (TIMER) were used as recent studies [10,11]; NKX3.2 was highly expressed in most cancers compared to normal tissues. Here, NKX3-2 is linked to neoplasm.